Eric Terrebonne

Pessac-sur-dordogne, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].

Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 07, 2026

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 02, 2025

The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors.

The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors.

Journal: Journal of neuro-oncology

Published: September 27, 2024

Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.

Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.

Journal: British journal of cancer

Published: September 20, 2023

Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study.

Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study.

Journal: JNCI cancer spectrum

Published: May 18, 2023

OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel.

OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel.

Journal: European journal of endocrinology

Published: April 06, 2023

Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.

Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.

Journal: Clinics and research in hepatology and gastroenterology

Published: December 30, 2022

Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.

Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 22, 2022

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 08, 2022

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 18, 2021

Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery.

Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 01, 2021

Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study.

Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study.

Journal: Cancers

Published: May 21, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026